0001493712 2025-06-01 2026-05-31 0001493712 2026-05-31 0001493712 2025-11-30 0001493712 2026-08-31 0001493712 2025-05-31 0001493712 2024-06-01 2025-05-31 0001493712 us-gaap:CommonStockMember 2025-06-01 2026-05-31 0001493712 us-gaap:AdditionalPaidInCapitalMember 2025-06-01 2026-05-31 0001493712 fil:Reserves1Member 2025-06-01 2026-05-31 0001493712 us-gaap:RetainedEarningsMember 2025-06-01 2026-05-31 0001493712 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-01 2026-05-31 0001493712 2024-05-31 0001493712 us-gaap:CommonStockMember 2024-05-31 0001493712 us-gaap:AdditionalPaidInCapitalMember 2024-05-31 0001493712 fil:Reserves1Member 2024-05-31 0001493712 us-gaap:RetainedEarningsMember 2024-05-31 0001493712 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-05-31 0001493712 us-gaap:CommonStockMember 2024-06-01 2025-05-31 0001493712 us-gaap:AdditionalPaidInCapitalMember 2024-06-01 2025-05-31 0001493712 fil:Reserves1Member 2024-06-01 2025-05-31 0001493712 us-gaap:RetainedEarningsMember 2024-06-01 2025-05-31 0001493712 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-01 2025-05-31 0001493712 us-gaap:CommonStockMember 2025-05-31 0001493712 us-gaap:AdditionalPaidInCapitalMember 2025-05-31 0001493712 fil:Reserves1Member 2025-05-31 0001493712 us-gaap:RetainedEarningsMember 2025-05-31 0001493712 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-05-31 0001493712 us-gaap:CommonStockMember 2026-05-31 0001493712 us-gaap:AdditionalPaidInCapitalMember 2026-05-31 0001493712 fil:Reserves1Member 2026-05-31 0001493712 us-gaap:RetainedEarningsMember 2026-05-31 0001493712 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-05-31 0001493712 2024-10-30 0001493712 2024-11-02 0001493712 fil:DueToTheCeoMember 2026-05-31 0001493712 fil:DueToTheCeoMember 2025-05-31 0001493712 fil:DueToCfoMember 2026-05-31 0001493712 fil:DueToCfoMember 2025-05-31 0001493712 fil:DueToAnEntityControlledByADirectorOfTheCompanyMember 2026-05-31 0001493712 fil:DueToAnEntityControlledByADirectorOfTheCompanyMember 2025-05-31 0001493712 fil:ManagementFeesIncurredToACeoMember 2025-06-01 2026-05-31 0001493712 fil:ManagementFeesIncurredToACeoMember 2024-06-01 2025-05-31 0001493712 fil:ManagementFeesIncurredToTheCfoMember 2025-06-01 2026-05-31 0001493712 fil:ManagementFeesIncurredToTheCfoMember 2024-06-01 2025-05-31 0001493712 fil:ConsultingFeesIncurredToAnEntityControlledByADirectorOfTheCompanyMember 2025-06-01 2026-05-31 0001493712 fil:ConsultingFeesIncurredToAnEntityControlledByADirectorOfTheCompanyMember 2024-06-01 2025-05-31 0001493712 fil:RelatedPartyLoansPayableMember 2026-05-31 0001493712 fil:RelatedPartyLoansPayable2Member 2026-05-31 0001493712 fil:RelatedPartyAdvancesMember 2026-05-31 0001493712 fil:RelatedPartyLoansPayableMember 2025-05-31 0001493712 fil:RelatedPartyLoansPayable2Member 2025-05-31 0001493712 fil:RelatedPartyAdvancesMember 2025-05-31 0001493712 fil:LoansToRichardJeffsMember 2025-06-01 2026-05-31 0001493712 fil:LoansToRichardJeffsMember 2026-05-31 0001493712 fil:LoansToRichardJeffsMember 2025-05-31 0001493712 fil:LoansToRicjardJeffsAt6Member 2026-05-31 0001493712 fil:LoansToRicjardJeffsAt10Member 2026-05-31 0001493712 fil:LoansToRichardJeffsMember 2024-06-01 2025-05-31 0001493712 fil:LoansToDavidJeffsMember 2026-05-31 0001493712 fil:LoansToDavidJeffsMember 2025-05-31 0001493712 fil:AdvancesFromDavidJeffsMember 2025-06-01 2026-05-31 0001493712 fil:AdvancesFromDavidJeffsMember 2024-06-01 2025-05-31 0001493712 fil:LoansToACompanyDavidJeffsIsADirectorOfMember 2026-05-31 0001493712 fil:LoansToACompanyDavidJeffsIsADirectorOfMember 2025-05-31 0001493712 fil:LoansToACompanyDavidJeffsIsADirectorOfMember 2025-06-01 2026-05-31 0001493712 fil:LoansToACompanyDavidJeffsIsADirectorOfMember 2024-06-01 2025-05-31 0001493712 fil:RelatedPartyLoanWithMrAmirMember 2026-05-31 0001493712 fil:RelatedPartyLoanWithMrAmirMember 2025-05-31 0001493712 fil:NotePayablesToMrAhdootMember 2026-05-31 0001493712 fil:RelatedPartyLoanWithMrAmirMember 2025-06-01 2026-05-31 0001493712 fil:RelatedPartyLoanWithMrAmirMember 2024-06-01 2025-05-31 0001493712 fil:NotePayablesToMrAhdootMember 2025-05-31 0001493712 fil:NotePayablesToMrAhdootMember 2025-06-01 2026-05-31 0001493712 fil:NotePayablesToMrAhdootMember 2024-06-01 2025-05-31 0001493712 fil:LoansToSusanJeffsMember 2025-06-01 2026-05-31 0001493712 fil:LoansToSusanJeffs2Member 2025-06-01 2026-05-31 0001493712 fil:LoansToSusanJeffsMember 2026-05-31 0001493712 fil:LoansToSusanJeffsMember 2025-05-31 0001493712 fil:LoansToSusanJeffsMember 2024-06-01 2025-05-31 0001493712 fil:PrepaidExpensesMember 2026-05-31 0001493712 fil:PrepaidExpensesMember 2025-05-31 0001493712 fil:ReceivablesAssociatedWithGstCellMedxCanadaMember 2026-05-31 0001493712 fil:ReceivablesAssociatedWithGstCellMedxCanadaMember 2025-05-31 0001493712 fil:AgreementWithInvestorAndPublicRelationsFirmMember 2025-06-01 2026-05-31 0001493712 fil:AdvisoryServicesAgreementWithAnInvestorRelationsFirmMember 2025-06-01 2026-05-31 0001493712 fil:AdvisoryServicesAgreementWithAnInvestorRelationsFirmMember 2026-05-31 0001493712 fil:DebtSettlementAmountMember 2024-06-01 2025-05-31 0001493712 fil:LossOnConversionOfDebtMember 2024-06-01 2025-05-31 0001493712 fil:AdmTronicsMember 2025-06-01 2026-05-31 0001493712 fil:ProprietaryMicrocurrentDeviceMember 2026-05-31 0001493712 fil:LoansToRichardJeffsMember 2026-06-01 2026-08-28 iso4217:USD shares iso4217:USD shares pure 0001493712 --05-31 false 2026 FY 10-K true 2026-05-31 false 000-54500 Stimcell Energetics Inc. NV 38-3939625 1130 Pender Street, West Suite 555 Vancouver BC V6E 4A4 844 238-2692 No No Yes Yes Non-accelerated Filer true false false false false 2427796 21141272 DMCL LLP Vancouver, Canada 1173

3057

14581

78397

6641

81454

21222

356302

322144

37674

26954

665321 448536 833477 469874

1892774

1267508

0.001

500000000

21141272

20141272

21141

20141

9470616

9146591

366493 366493

-11756931

-10861556

87361

82045

-1811320

-1246286

81454

21222

138790

137488

-5501

-17157

382560

213452

90000

209176 64009

826027

522106

-5931

69348

38256

-895375

-566293

5316

13047

-890059

-553246

-0.04

-0.03

20747436

19843258

19816272

19816

9013501

366493

-10295263

68998

-826455

250000

250

107500

107750

75000

22425

22500

3165

-566293

13047

20141272

20141

9146591

366493

-10861556

82045

-1246286

804795

805

265639

266444

195205 195 58386 0 0 0 58581

-895375

5316

21141272

21141

9470616

366493

-11756931

87361

-1811320

-895375

-566293

63295

31515

6053

6741

-5931

266444

107750

-4848

-15341

13183

3930

28856

42857

10725

-1108

216256

219596

-312081

-141600

300582

112858

300582

112858

-25

-92

-11524

-28834

14581

43415

3057

14581

NOTE 1 - ORGANIZATION AND NATURE OF OPERATIONS StimCell Energetics Inc. (“Stimcell”, or the “Company”) was incorporated under the laws of the State of Nevada. On April 26, 2016, the Company formed a subsidiary, Cell MedX (Canada) Corp. (“Cell MedX Canada” or the “Subsidiary”), under the laws of the Province of British Columbia. Stimcell is a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. Effective November 1, 2024, the Company completed a 1-for-15 reverse split (the “Reverse Split”) of its common stock. As a result of the Reverse Split, the Company’s authorized capital was decreased from 7,500,000,000 shares of common stock with par value of $0.001, of which 297,236,373 shares were outstanding immediately prior to the Reverse Split, to 500,000,000 shares of common stock with par value of $0.001, of which 19,816,272 were outstanding. All share and per-share amounts in these consolidated financial statements have been retrospectively adjusted. Concurrent with the Reverse Split, the Company amended its articles of incorporation to change the Company’s name from “Cell MedX Corp.” to “Stimcell Energetics Inc.” (the “Name Change”). Going concern The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As of May 31, 2026, the Company has not achieved profitable operations and has accumulated a deficit of $11,756,931. Continuation as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet obligations and pay its liabilities arising from normal business operations when they come due, and ultimately upon its ability to achieve profitable operations. The outcome of these matters cannot be predicted with certainty at this time, which raises substantial doubt that the Company will be able to continue as a going concern. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern. Management intends to obtain additional funding by borrowing funds from its directors and officers, issuing promissory notes, and/or private placement of common stock.

1-for-15

7500000000

0.001

297236373

500000000

0.001

19816272

-11756931

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The audited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are presented in US dollars. Principles of consolidation The consolidated financial statements include the accounts of the Company and its subsidiary, Cell MedX Canada. On consolidation, all intercompany balances and transactions are eliminated. Accounting estimates The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, fair value of financial instruments and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Foreign currency translations and transactions The Company’s functional and reporting currency is the United States dollar. Foreign denominated monetary assets and liabilities are translated into their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenues and expenses are translated at average rates of exchange during the period. Related translation adjustments as well as gains or losses resulting from foreign currency transactions are reported as part of operating expenses on the statement of operations. The functional currency of Cell MedX Canada is the Canadian dollar. On consolidation, the subsidiary translates its assets and liabilities to U.S. dollars using foreign exchange rates which prevailed at the balance sheet date, and translates its revenues and expenses using average exchange rates during the period. Gains and losses arising on settlement of foreign currency denominated transactions or balances are included in other comprehensive income/loss. The Company has not, to the date of these financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations. Research and development costs The Company expenses all in-house research and development costs in the period they were incurred. Acquired research and development costs are capitalized to the extent that the sum of the undiscounted cash flows expected to result from the asset can be reasonably estimated or may be verified by an appraisal in certain instances. In all other instances, the costs are expensed in the period in which they were incurred. Acquired research and development costs for a particular research and development project that have no future economic value are expensed as research and development costs at the time the costs are incurred. Income taxes Income tax expense is based on pre-tax financial accounting income. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. The components of the deferred tax assets and liabilities are individually classified as current and non-current based on their characteristics. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not some portion or all of the deferred tax assets will not be realized. Earnings (Loss) Per Share Basic and diluted loss per share are computed in accordance with ASC 260. Basic loss per share is calculated by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution from common share equivalents (e.g., warrants) using the treasury stock method; however, for the periods presented, the effect of such instruments was anti-dilutive, and therefore diluted loss per share is the same as basic loss per share. The following table presents the calculation of the loss per share: <table style="border-collapse:collapse;width:99.16%"><tr><td style="width:65.68%;border-top:0.5pt solid #000000" valign="top"> </td><td colspan="5" style="width:34.32%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Years ended May 31, </td></tr> <tr style="height:11.3pt"><td style="width:65.68%;border-bottom:0.5pt solid #000000" valign="top"> </td><td colspan="2" style="width:16.14%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">2026 </td><td style="width:2.56%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:15.62%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:65.68%;border-top:0.5pt solid #000000" valign="top">Net loss attributable to common shareholders </td><td style="background-color:#DBE5F1;width:2.96%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.18%;border-top:0.5pt solid #000000" valign="bottom">(895,375) </td><td style="background-color:#DBE5F1;width:2.56%;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:2.58%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.04%;border-top:0.5pt solid #000000" valign="bottom">(566,293) </td></tr> <tr><td style="width:65.68%;border-bottom:0.5pt solid #000000" valign="top">Weighted-average common shares outstanding </td><td style="width:2.96%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:13.18%;border-bottom:0.5pt solid #000000" valign="bottom">20,747,436 </td><td style="width:2.56%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:2.58%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:13.04%;border-bottom:0.5pt solid #000000" valign="bottom">19,843,258 </td></tr> <tr><td style="background-color:#DBE5F1;width:65.68%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top">Loss per common share (basic and diluted) </td><td style="background-color:#DBE5F1;width:2.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.18%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">(0.04) </td><td style="background-color:#DBE5F1;width:2.56%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:2.58%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.04%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">(0.03) </td></tr> </table> Fair value measurements The carrying amounts of cash, other current assets, accounts payable, accrued liabilities, notes and advances payable, and amounts due to related parties approximate their fair values due to the short-term nature and/or the terms of these instruments. The fair value hierarchy under GAAP prioritizes the inputs used in valuation techniques into three levels: <kbd style="position:absolute;font:10pt Times New Roman;margin-left:-72pt">Level 1 -</kbd>quoted prices (unadjusted) in active markets for identical assets or liabilities; <kbd style="position:absolute;font:10pt Times New Roman;margin-left:-72pt">Level 2 -</kbd>observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and <kbd style="position:absolute;font:10pt Times New Roman;margin-left:-72pt">Level 3 -</kbd>assets and liabilities whose significant value drivers are unobservable by little or no market activity and that are significant to the fair value of the assets or liabilities. Certain assets and liabilities are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). There were no assets or liabilities measured at fair value on a nonrecurring basis during the years ended May 31, 2026 and 2025. Stock options and other stock-based compensation The Company accounts for the granting of share purchase options to employees using the fair value method, whereby all awards to employees are recorded at fair value on the date of the grant. The fair value of all share purchase options is expensed over the vesting period with a corresponding increase to additional capital surplus. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional paid-in capital, is recorded as an increase to share capital. The Company uses the Black-Scholes Option Pricing Model to calculate the fair value of share purchase options. Option pricing models require the input of highly subjective assumptions, including the expected price volatility. Changes in these assumptions can materially affect the fair value estimate. Recent accounting pronouncements In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require enhanced annual disclosures regarding an entity’s income tax rate reconciliation and income taxes paid, including additional disaggregation of certain information by jurisdiction. The amendments became effective for the Company for the fiscal year beginning June 1, 2025. The Company adopted ASU 2023-09 during the year ended May 31, 2026. The adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows, as the amendments primarily relate to financial statement disclosures. In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public business entities to provide additional disclosures regarding certain expenses included in the expense captions presented on the statement of operations. In January 2025, the FASB issued ASU 2025-01, which clarified the effective date of ASU 2024-03. The amendments are effective for annual reporting periods beginning after December 15, 2026, and for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of adopting the amendments on its consolidated financial statement disclosures. Management has evaluated other recently issued accounting pronouncements and does not believe that the adoption of such pronouncements will have a material effect on the Company’s consolidated financial statements and related disclosures.

Basis of presentation The audited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are presented in US dollars.

Principles of consolidation The consolidated financial statements include the accounts of the Company and its subsidiary, Cell MedX Canada. On consolidation, all intercompany balances and transactions are eliminated.

Accounting estimates The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, fair value of financial instruments and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Foreign currency translations and transactions The Company’s functional and reporting currency is the United States dollar. Foreign denominated monetary assets and liabilities are translated into their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenues and expenses are translated at average rates of exchange during the period. Related translation adjustments as well as gains or losses resulting from foreign currency transactions are reported as part of operating expenses on the statement of operations. The functional currency of Cell MedX Canada is the Canadian dollar. On consolidation, the subsidiary translates its assets and liabilities to U.S. dollars using foreign exchange rates which prevailed at the balance sheet date, and translates its revenues and expenses using average exchange rates during the period. Gains and losses arising on settlement of foreign currency denominated transactions or balances are included in other comprehensive income/loss. The Company has not, to the date of these financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.

Research and development costs The Company expenses all in-house research and development costs in the period they were incurred. Acquired research and development costs are capitalized to the extent that the sum of the undiscounted cash flows expected to result from the asset can be reasonably estimated or may be verified by an appraisal in certain instances. In all other instances, the costs are expensed in the period in which they were incurred. Acquired research and development costs for a particular research and development project that have no future economic value are expensed as research and development costs at the time the costs are incurred.

Income taxes Income tax expense is based on pre-tax financial accounting income. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. The components of the deferred tax assets and liabilities are individually classified as current and non-current based on their characteristics. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not some portion or all of the deferred tax assets will not be realized.

Earnings (Loss) Per Share Basic and diluted loss per share are computed in accordance with ASC 260. Basic loss per share is calculated by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution from common share equivalents (e.g., warrants) using the treasury stock method; however, for the periods presented, the effect of such instruments was anti-dilutive, and therefore diluted loss per share is the same as basic loss per share. The following table presents the calculation of the loss per share: <table style="border-collapse:collapse;width:99.16%"><tr><td style="width:65.68%;border-top:0.5pt solid #000000" valign="top"> </td><td colspan="5" style="width:34.32%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Years ended May 31, </td></tr> <tr style="height:11.3pt"><td style="width:65.68%;border-bottom:0.5pt solid #000000" valign="top"> </td><td colspan="2" style="width:16.14%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">2026 </td><td style="width:2.56%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:15.62%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:65.68%;border-top:0.5pt solid #000000" valign="top">Net loss attributable to common shareholders </td><td style="background-color:#DBE5F1;width:2.96%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.18%;border-top:0.5pt solid #000000" valign="bottom">(895,375) </td><td style="background-color:#DBE5F1;width:2.56%;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:2.58%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.04%;border-top:0.5pt solid #000000" valign="bottom">(566,293) </td></tr> <tr><td style="width:65.68%;border-bottom:0.5pt solid #000000" valign="top">Weighted-average common shares outstanding </td><td style="width:2.96%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:13.18%;border-bottom:0.5pt solid #000000" valign="bottom">20,747,436 </td><td style="width:2.56%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:2.58%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:13.04%;border-bottom:0.5pt solid #000000" valign="bottom">19,843,258 </td></tr> <tr><td style="background-color:#DBE5F1;width:65.68%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top">Loss per common share (basic and diluted) </td><td style="background-color:#DBE5F1;width:2.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.18%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">(0.04) </td><td style="background-color:#DBE5F1;width:2.56%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:2.58%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.04%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">(0.03) </td></tr> </table>

<table style="border-collapse:collapse;width:99.16%"><tr><td style="width:65.68%;border-top:0.5pt solid #000000" valign="top"> </td><td colspan="5" style="width:34.32%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Years ended May 31, </td></tr> <tr style="height:11.3pt"><td style="width:65.68%;border-bottom:0.5pt solid #000000" valign="top"> </td><td colspan="2" style="width:16.14%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">2026 </td><td style="width:2.56%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:15.62%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:65.68%;border-top:0.5pt solid #000000" valign="top">Net loss attributable to common shareholders </td><td style="background-color:#DBE5F1;width:2.96%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.18%;border-top:0.5pt solid #000000" valign="bottom">(895,375) </td><td style="background-color:#DBE5F1;width:2.56%;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:2.58%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.04%;border-top:0.5pt solid #000000" valign="bottom">(566,293) </td></tr> <tr><td style="width:65.68%;border-bottom:0.5pt solid #000000" valign="top">Weighted-average common shares outstanding </td><td style="width:2.96%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:13.18%;border-bottom:0.5pt solid #000000" valign="bottom">20,747,436 </td><td style="width:2.56%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:2.58%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="width:13.04%;border-bottom:0.5pt solid #000000" valign="bottom">19,843,258 </td></tr> <tr><td style="background-color:#DBE5F1;width:65.68%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top">Loss per common share (basic and diluted) </td><td style="background-color:#DBE5F1;width:2.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.18%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">(0.04) </td><td style="background-color:#DBE5F1;width:2.56%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:2.58%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:13.04%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">(0.03) </td></tr> </table>

-895375

-566293

20747436

19843258

-0.04

-0.03

Fair value measurements The carrying amounts of cash, other current assets, accounts payable, accrued liabilities, notes and advances payable, and amounts due to related parties approximate their fair values due to the short-term nature and/or the terms of these instruments. The fair value hierarchy under GAAP prioritizes the inputs used in valuation techniques into three levels: <kbd style="position:absolute;font:10pt Times New Roman;margin-left:-72pt">Level 1 -</kbd>quoted prices (unadjusted) in active markets for identical assets or liabilities; <kbd style="position:absolute;font:10pt Times New Roman;margin-left:-72pt">Level 2 -</kbd>observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and <kbd style="position:absolute;font:10pt Times New Roman;margin-left:-72pt">Level 3 -</kbd>assets and liabilities whose significant value drivers are unobservable by little or no market activity and that are significant to the fair value of the assets or liabilities. Certain assets and liabilities are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). There were no assets or liabilities measured at fair value on a nonrecurring basis during the years ended May 31, 2026 and 2025.

Stock options and other stock-based compensation The Company accounts for the granting of share purchase options to employees using the fair value method, whereby all awards to employees are recorded at fair value on the date of the grant. The fair value of all share purchase options is expensed over the vesting period with a corresponding increase to additional capital surplus. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional paid-in capital, is recorded as an increase to share capital. The Company uses the Black-Scholes Option Pricing Model to calculate the fair value of share purchase options. Option pricing models require the input of highly subjective assumptions, including the expected price volatility. Changes in these assumptions can materially affect the fair value estimate.

Recent accounting pronouncements In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require enhanced annual disclosures regarding an entity’s income tax rate reconciliation and income taxes paid, including additional disaggregation of certain information by jurisdiction. The amendments became effective for the Company for the fiscal year beginning June 1, 2025. The Company adopted ASU 2023-09 during the year ended May 31, 2026. The adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows, as the amendments primarily relate to financial statement disclosures. In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public business entities to provide additional disclosures regarding certain expenses included in the expense captions presented on the statement of operations. In January 2025, the FASB issued ASU 2025-01, which clarified the effective date of ASU 2024-03. The amendments are effective for annual reporting periods beginning after December 15, 2026, and for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of adopting the amendments on its consolidated financial statement disclosures. Management has evaluated other recently issued accounting pronouncements and does not believe that the adoption of such pronouncements will have a material effect on the Company’s consolidated financial statements and related disclosures.

NOTE 3 - RELATED PARTY TRANSACTIONS Amounts due to related parties, other than notes payable to related parties (Note 4) at May 31, 2026 and 2025: <table style="border-collapse:collapse;width:102.78%"><tr><td style="width:67.68%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"></td><td colspan="2" style="width:14.74%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">May 31, 2026 </td><td style="width:2.76%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:14.82%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">May 31, 2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:67.68%;border-top:0.5pt solid #000000" valign="top">Due to the Chief Executive Officer (“CEO”), President and Director </td><td style="background-color:#DBE5F1;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:10.76%;border-top:0.5pt solid #000000" valign="bottom">250,019 </td><td style="background-color:#DBE5F1;width:2.76%;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:4.26%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:10.56%;border-top:0.5pt solid #000000" valign="bottom">144,237 </td></tr> <tr><td style="width:67.68%" valign="top">Due to the Chief Financial Officer (“CFO”) </td><td valign="bottom"> </td><td style="width:10.76%" valign="bottom">11,760 </td><td style="width:2.76%" valign="bottom"> </td><td style="width:4.26%" valign="bottom"> </td><td style="width:10.56%" valign="bottom">8,778 </td></tr> <tr><td style="background-color:#DBE5F1;width:67.68%" valign="top">Due to an entity controlled by a director of the Company </td><td style="background-color:#DBE5F1" valign="bottom"> </td><td style="background-color:#DBE5F1;width:10.76%" valign="bottom">403,542 </td><td style="background-color:#DBE5F1;width:2.76%" valign="bottom"> </td><td style="background-color:#DBE5F1;width:4.26%" valign="bottom"> </td><td style="background-color:#DBE5F1;width:10.56%" valign="bottom">295,521 </td></tr> <tr><td style="width:67.68%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top">Due to related parties(1) </td><td style="border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:10.76%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">665,321 </td><td style="width:2.76%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"> </td><td style="width:4.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:10.56%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">448,536 </td></tr> </table> <kbd style="position:absolute;font:10pt Times New Roman;margin-left:-36pt">(1)</kbd>The amounts due to related parties are unsecured, due on demand, and bear no interest. During the years ended May 31, 2026 and 2025, the Company had the following transactions with related parties: <table style="border-collapse:collapse;width:102.88%"><tr><td style="width:67.26%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top"></td><td colspan="2" style="width:14.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top">May 31, 2026 </td><td style="width:2.82%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top"> </td><td colspan="2" style="width:14.94%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top">May 31, 2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:67.26%;border-top:0.5pt solid #000000" valign="top">Management fees incurred to the CEO, President and director </td><td style="background-color:#DBE5F1;width:4.68%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:10.28%;border-top:0.5pt solid #000000" valign="bottom">90,000 </td><td style="background-color:#DBE5F1;width:2.82%;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:3.74%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:11.2%;border-top:0.5pt solid #000000" valign="bottom">90,000 </td></tr> <tr><td style="width:67.26%" valign="top">Consulting fees incurred to the CFO </td><td style="width:4.68%" valign="bottom"> </td><td style="width:10.28%" valign="bottom">30,000 </td><td style="width:2.82%" valign="bottom"> </td><td style="width:3.74%" valign="bottom"> </td><td style="width:11.2%" valign="bottom">30,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:67.26%;border-bottom:0.5pt solid #000000" valign="top">Consulting fees incurred to an entity controlled by a director of the Company </td><td style="background-color:#DBE5F1;width:4.68%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:10.28%;border-bottom:0.5pt solid #000000" valign="bottom">108,790 </td><td style="background-color:#DBE5F1;width:2.82%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:3.74%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:11.2%;border-bottom:0.5pt solid #000000" valign="bottom">107,488 </td></tr> <tr><td style="width:67.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top">Total transactions with related parties </td><td style="width:4.68%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:10.28%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">228,790 </td><td style="width:2.82%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"> </td><td style="width:3.74%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:11.2%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">227,488 </td></tr> </table>

<table style="border-collapse:collapse;width:102.78%"><tr><td style="width:67.68%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"></td><td colspan="2" style="width:14.74%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">May 31, 2026 </td><td style="width:2.76%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:14.82%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">May 31, 2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:67.68%;border-top:0.5pt solid #000000" valign="top">Due to the Chief Executive Officer (“CEO”), President and Director </td><td style="background-color:#DBE5F1;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:10.76%;border-top:0.5pt solid #000000" valign="bottom">250,019 </td><td style="background-color:#DBE5F1;width:2.76%;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:4.26%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:10.56%;border-top:0.5pt solid #000000" valign="bottom">144,237 </td></tr> <tr><td style="width:67.68%" valign="top">Due to the Chief Financial Officer (“CFO”) </td><td valign="bottom"> </td><td style="width:10.76%" valign="bottom">11,760 </td><td style="width:2.76%" valign="bottom"> </td><td style="width:4.26%" valign="bottom"> </td><td style="width:10.56%" valign="bottom">8,778 </td></tr> <tr><td style="background-color:#DBE5F1;width:67.68%" valign="top">Due to an entity controlled by a director of the Company </td><td style="background-color:#DBE5F1" valign="bottom"> </td><td style="background-color:#DBE5F1;width:10.76%" valign="bottom">403,542 </td><td style="background-color:#DBE5F1;width:2.76%" valign="bottom"> </td><td style="background-color:#DBE5F1;width:4.26%" valign="bottom"> </td><td style="background-color:#DBE5F1;width:10.56%" valign="bottom">295,521 </td></tr> <tr><td style="width:67.68%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top">Due to related parties(1) </td><td style="border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:10.76%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">665,321 </td><td style="width:2.76%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"> </td><td style="width:4.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:10.56%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">448,536 </td></tr> </table>

250019 144237 11760 8778 403542 295521 665321 448536 <table style="border-collapse:collapse;width:102.88%"><tr><td style="width:67.26%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top"></td><td colspan="2" style="width:14.96%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top">May 31, 2026 </td><td style="width:2.82%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top"> </td><td colspan="2" style="width:14.94%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="top">May 31, 2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:67.26%;border-top:0.5pt solid #000000" valign="top">Management fees incurred to the CEO, President and director </td><td style="background-color:#DBE5F1;width:4.68%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:10.28%;border-top:0.5pt solid #000000" valign="bottom">90,000 </td><td style="background-color:#DBE5F1;width:2.82%;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:3.74%;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:11.2%;border-top:0.5pt solid #000000" valign="bottom">90,000 </td></tr> <tr><td style="width:67.26%" valign="top">Consulting fees incurred to the CFO </td><td style="width:4.68%" valign="bottom"> </td><td style="width:10.28%" valign="bottom">30,000 </td><td style="width:2.82%" valign="bottom"> </td><td style="width:3.74%" valign="bottom"> </td><td style="width:11.2%" valign="bottom">30,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:67.26%;border-bottom:0.5pt solid #000000" valign="top">Consulting fees incurred to an entity controlled by a director of the Company </td><td style="background-color:#DBE5F1;width:4.68%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:10.28%;border-bottom:0.5pt solid #000000" valign="bottom">108,790 </td><td style="background-color:#DBE5F1;width:2.82%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:3.74%;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:11.2%;border-bottom:0.5pt solid #000000" valign="bottom">107,488 </td></tr> <tr><td style="width:67.26%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top">Total transactions with related parties </td><td style="width:4.68%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:10.28%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">228,790 </td><td style="width:2.82%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"> </td><td style="width:3.74%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:11.2%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">227,488 </td></tr> </table>

90000

30000

108790

107488

228790

227488

NOTE 4 - NOTES AND ADVANCES DUE TO RELATED PARTIES The tables below summarize the loans and advances due and payable to related parties as at May 31, 2026 and 2025: <table style="border-collapse:collapse;width:100%"><tr><td colspan="8" style="width:468pt;border-bottom:0.5pt solid #000000" valign="bottom">As at May 31, 2026 </td></tr> <tr><td colspan="2" style="width:82.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Principal Outstanding </td><td style="width:63pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Interest Rate per Annum </td><td style="width:172.7pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:69.3pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Accrued Interest </td><td colspan="2" style="width:80.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Total Book Value </td></tr> <tr><td style="background-color:#DBE5F1;width:25.95pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.55pt;border-top:0.5pt solid #000000" valign="bottom">78,729 </td><td style="background-color:#DBE5F1;width:63pt;border-top:0.5pt solid #000000" valign="middle">6% </td><td style="background-color:#DBE5F1;width:172.7pt;border-top:0.5pt solid #000000" valign="middle">Related party loans payable (1) </td><td style="background-color:#DBE5F1;width:19.3pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:50pt;border-top:0.5pt solid #000000" valign="bottom">26,090 </td><td style="background-color:#DBE5F1;width:22pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:58.5pt;border-top:0.5pt solid #000000" valign="bottom">104,819 </td></tr> <tr><td style="width:25.95pt" valign="bottom"> </td><td style="width:56.55pt" valign="bottom">612,335 </td><td style="width:63pt" valign="middle">10% </td><td style="width:172.7pt" valign="middle">Related party loans payable (1) </td><td style="width:19.3pt" valign="bottom"> </td><td style="width:50pt" valign="bottom">105,452 </td><td style="width:22pt" valign="bottom"> </td><td style="width:58.5pt" valign="bottom">717,787 </td></tr> <tr><td style="background-color:#DBE5F1;width:25.95pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:56.55pt;border-bottom:0.5pt solid #000000" valign="bottom">10,871 </td><td style="background-color:#DBE5F1;width:63pt;border-bottom:0.5pt solid #000000" valign="middle">0% </td><td style="background-color:#DBE5F1;width:172.7pt;border-bottom:0.5pt solid #000000" valign="middle">Advances(2) </td><td style="background-color:#DBE5F1;width:19.3pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:50pt;border-bottom:0.5pt solid #000000" valign="bottom">- </td><td style="background-color:#DBE5F1;width:22pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:58.5pt;border-bottom:0.5pt solid #000000" valign="bottom">10,871 </td></tr> <tr><td style="width:25.95pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:56.55pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">701,935 </td><td style="width:63pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"> </td><td style="width:172.7pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"> </td><td style="width:19.3pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:50pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">131,542 </td><td style="width:22pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:58.5pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">833,477 </td></tr> </table> <table style="border-collapse:collapse;width:100%"><tr><td colspan="8" style="width:468pt;border-bottom:0.5pt solid #000000" valign="bottom">As at May 31, 2025 </td></tr> <tr><td colspan="2" style="width:82.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Principal Outstanding </td><td style="width:63pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Interest Rate per Annum </td><td style="width:172.7pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:69.3pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Accrued Interest </td><td colspan="2" style="width:80.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Total Book Value </td></tr> <tr><td style="background-color:#DBE5F1;width:25.95pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.55pt;border-top:0.5pt solid #000000" valign="bottom">78,884 </td><td style="background-color:#DBE5F1;width:63pt;border-top:0.5pt solid #000000" valign="middle">6% </td><td style="background-color:#DBE5F1;width:172.7pt;border-top:0.5pt solid #000000" valign="middle">Related party loans payable (1) </td><td style="background-color:#DBE5F1;width:19.3pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:50pt;border-top:0.5pt solid #000000" valign="bottom">20,038 </td><td style="background-color:#DBE5F1;width:22pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:58.5pt;border-top:0.5pt solid #000000" valign="bottom">98,923 </td></tr> <tr><td style="width:25.95pt" valign="bottom"> </td><td style="width:56.55pt" valign="bottom">311,782 </td><td style="width:63pt" valign="middle">10% </td><td style="width:172.7pt" valign="middle">Related party loans payable (1) </td><td style="width:19.3pt" valign="bottom"> </td><td style="width:50pt" valign="bottom">48,267 </td><td style="width:22pt" valign="bottom"> </td><td style="width:58.5pt" valign="bottom">360,049 </td></tr> <tr><td style="background-color:#DBE5F1;width:25.95pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:56.55pt;border-bottom:0.5pt solid #000000" valign="bottom">10,902 </td><td style="background-color:#DBE5F1;width:63pt;border-bottom:0.5pt solid #000000" valign="middle">0% </td><td style="background-color:#DBE5F1;width:172.7pt;border-bottom:0.5pt solid #000000" valign="middle">Advances(2) </td><td style="background-color:#DBE5F1;width:19.3pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:50pt;border-bottom:0.5pt solid #000000" valign="bottom">- </td><td style="background-color:#DBE5F1;width:22pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:58.5pt;border-bottom:0.5pt solid #000000" valign="bottom">10,902 </td></tr> <tr><td style="width:25.95pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:56.55pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">401,568 </td><td style="width:63pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"> </td><td style="width:172.7pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"> </td><td style="width:19.3pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:50pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">68,305 </td><td style="width:22pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:58.5pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">469,874 </td></tr> </table> (1) Related Party Loans Payable As of May 31, 2026, the Company owed a total of $104,819 under 6% notes payable due to related parties (May 31, 2025 - $98,923), of which $26,090 was associated with interest accrued on the principal balances owed under the notes payable (May 31, 2025 - $20,038). As of May 31, 2026, the Company owed a total of $717,787 under 10% notes payable due to related parties (May 31, 2025 - $360,049), of which $105,452 was associated with interest accrued on the principal balances owed under the notes payable (May 31, 2025 - $48,267). Notes payable with Mr. Richard Jeffs During the year ended May 31, 2026, the Company borrowed $200,000 from Mr. Richard Jeffs under an unsecured credit line, which allows the Company to draw up to $200,000 at 10% per annum and is payable on demand (Note 9). As of May 31, 2026, the Company owed a total of $316,937 (May 31, 2025 - $94,253) to Mr. Richard Jeffs, a significant shareholder of the Company and the father of the Company’s CEO and President, Mr. David Jeffs. A total of $70,602 (including accrued interest of $16,874) was borrowed under unsecured notes payable, which accrue interest at a rate of 6% per annum, compounded monthly, and are due on demand. The remaining amount of $246,335 (including accrued interest of $19,158) was borrowed under unsecured credit lines, which allow the Company to draw up to CAD$100,000 and up to $350,000, as amended subsequent to May 31, 2026 (Note 9), at 10% per annum, compounded monthly and payable on demand. During the year ended May 31, 2026, the Company recorded $22,963 in interest on the notes payable and the funds borrowed under the credit lines with Mr. Richard Jeffs (May 31, 2025 - $4,115). Notes payable with Mr. David Jeffs As of May 31, 2026, the Company owed a total of $52,570 under loan agreements with Mr. David Jeffs, the Company’s CEO, director, and a significant shareholder (May 31, 2025 - $47,615). The loans accrue 10% annual interest, compounded monthly, are unsecured, and are payable on demand. The $30,000 loan was payable on April 24, 2023, and is therefore in default as of the date of these condensed consolidated financial statements. During the year ended May 31, 2026, the Company recorded $4,984 in interest on the principal (May 31, 2025 - $4,445). As of May 31, 2026, the Company owed a total of $34,217 under a loan agreement with a company of which Mr. David Jeffs is a director (May 31, 2025 - $32,229). The loan bears interest at 6% per annum compounded monthly, is unsecured, and is payable on demand. During the year ended May 31, 2026, the Company recorded $1,988 in interest on the principal (May 31, 2025 - $1,872). Notes payable with Mr. Amir Vahabzadeh As of May 31, 2026, the Company owed a total of $204,700 under loan agreements with Mr. Vahabzadeh, a director and a significant shareholder (May 31, 2025 - $185,297). The loans are unsecured and carry a 10% annual interest rate, compounded monthly. A $30,000 note payable included in the total due was payable on April 24, 2023, and, as of the date of these condensed consolidated financial statements, is in default. The remaining notes payable, totaling $130,000, are payable on demand. During the year ended May 31, 2026, the Company recorded $19,403 in interest on the principal (May 31, 2025 - $13,901). Notes payable with a significant shareholder As of May 31, 2026, the Company owed $80,374 (May 31, 2025 - $72,756) under unsecured notes payable with the Company’s significant shareholder. The loans are unsecured and carry a 10% annual interest rate, compounded monthly. During the year ended May 31, 2026, the Company recorded $7,618 in interest on the principal (May 31, 2025 - $6,896). Notes payable with Mrs. Susan Jeffs During the year ended May 31, 2026, the Company borrowed $50,582 from Mrs. Susan Jeffs, mother of Mr. David Jeffs, under an unsecured credit line, which allows the Company to draw up to CAD$250,000, and a further $50,000 under an unsecured credit line, which allows the Company to draw up to $100,000. Both credit lines accumulate interest at 10% per annum and are payable on demand. As of May 31, 2026, the Company owed $133,808 (May 31, 2025 - $26,822) under unsecured credit lines with Mrs. Susan Jeffs. During the year ended May 31, 2026, the Company recorded $6,339 in interest on the principal (May 31, 2025 - $285). (2) Advances Payable As of May 31, 2026, the Company owed a total of $10,871 (May 31, 2025 - $10,902) for an advance the Company received in its fiscal 2020 year from an entity controlled by Mr. David Jeffs. The advance is non-interest-bearing, unsecured, and payable on demand.

<table style="border-collapse:collapse;width:100%"><tr><td colspan="8" style="width:468pt;border-bottom:0.5pt solid #000000" valign="bottom">As at May 31, 2026 </td></tr> <tr><td colspan="2" style="width:82.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Principal Outstanding </td><td style="width:63pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Interest Rate per Annum </td><td style="width:172.7pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:69.3pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Accrued Interest </td><td colspan="2" style="width:80.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Total Book Value </td></tr> <tr><td style="background-color:#DBE5F1;width:25.95pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.55pt;border-top:0.5pt solid #000000" valign="bottom">78,729 </td><td style="background-color:#DBE5F1;width:63pt;border-top:0.5pt solid #000000" valign="middle">6% </td><td style="background-color:#DBE5F1;width:172.7pt;border-top:0.5pt solid #000000" valign="middle">Related party loans payable (1) </td><td style="background-color:#DBE5F1;width:19.3pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:50pt;border-top:0.5pt solid #000000" valign="bottom">26,090 </td><td style="background-color:#DBE5F1;width:22pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:58.5pt;border-top:0.5pt solid #000000" valign="bottom">104,819 </td></tr> <tr><td style="width:25.95pt" valign="bottom"> </td><td style="width:56.55pt" valign="bottom">612,335 </td><td style="width:63pt" valign="middle">10% </td><td style="width:172.7pt" valign="middle">Related party loans payable (1) </td><td style="width:19.3pt" valign="bottom"> </td><td style="width:50pt" valign="bottom">105,452 </td><td style="width:22pt" valign="bottom"> </td><td style="width:58.5pt" valign="bottom">717,787 </td></tr> <tr><td style="background-color:#DBE5F1;width:25.95pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:56.55pt;border-bottom:0.5pt solid #000000" valign="bottom">10,871 </td><td style="background-color:#DBE5F1;width:63pt;border-bottom:0.5pt solid #000000" valign="middle">0% </td><td style="background-color:#DBE5F1;width:172.7pt;border-bottom:0.5pt solid #000000" valign="middle">Advances(2) </td><td style="background-color:#DBE5F1;width:19.3pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:50pt;border-bottom:0.5pt solid #000000" valign="bottom">- </td><td style="background-color:#DBE5F1;width:22pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:58.5pt;border-bottom:0.5pt solid #000000" valign="bottom">10,871 </td></tr> <tr><td style="width:25.95pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:56.55pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">701,935 </td><td style="width:63pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"> </td><td style="width:172.7pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"> </td><td style="width:19.3pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:50pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">131,542 </td><td style="width:22pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:58.5pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">833,477 </td></tr> </table> <table style="border-collapse:collapse;width:100%"><tr><td colspan="8" style="width:468pt;border-bottom:0.5pt solid #000000" valign="bottom">As at May 31, 2025 </td></tr> <tr><td colspan="2" style="width:82.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Principal Outstanding </td><td style="width:63pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Interest Rate per Annum </td><td style="width:172.7pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:69.3pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Accrued Interest </td><td colspan="2" style="width:80.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Total Book Value </td></tr> <tr><td style="background-color:#DBE5F1;width:25.95pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.55pt;border-top:0.5pt solid #000000" valign="bottom">78,884 </td><td style="background-color:#DBE5F1;width:63pt;border-top:0.5pt solid #000000" valign="middle">6% </td><td style="background-color:#DBE5F1;width:172.7pt;border-top:0.5pt solid #000000" valign="middle">Related party loans payable (1) </td><td style="background-color:#DBE5F1;width:19.3pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:50pt;border-top:0.5pt solid #000000" valign="bottom">20,038 </td><td style="background-color:#DBE5F1;width:22pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:58.5pt;border-top:0.5pt solid #000000" valign="bottom">98,923 </td></tr> <tr><td style="width:25.95pt" valign="bottom"> </td><td style="width:56.55pt" valign="bottom">311,782 </td><td style="width:63pt" valign="middle">10% </td><td style="width:172.7pt" valign="middle">Related party loans payable (1) </td><td style="width:19.3pt" valign="bottom"> </td><td style="width:50pt" valign="bottom">48,267 </td><td style="width:22pt" valign="bottom"> </td><td style="width:58.5pt" valign="bottom">360,049 </td></tr> <tr><td style="background-color:#DBE5F1;width:25.95pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:56.55pt;border-bottom:0.5pt solid #000000" valign="bottom">10,902 </td><td style="background-color:#DBE5F1;width:63pt;border-bottom:0.5pt solid #000000" valign="middle">0% </td><td style="background-color:#DBE5F1;width:172.7pt;border-bottom:0.5pt solid #000000" valign="middle">Advances(2) </td><td style="background-color:#DBE5F1;width:19.3pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:50pt;border-bottom:0.5pt solid #000000" valign="bottom">- </td><td style="background-color:#DBE5F1;width:22pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:58.5pt;border-bottom:0.5pt solid #000000" valign="bottom">10,902 </td></tr> <tr><td style="width:25.95pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:56.55pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">401,568 </td><td style="width:63pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"> </td><td style="width:172.7pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"> </td><td style="width:19.3pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:50pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">68,305 </td><td style="width:22pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:58.5pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">469,874 </td></tr> </table>

78729

0.06

26090

104819

612335

0.10

105452

717787

10871

701935

131542

833477

78884

0.06

20038

98923

311782

0.10

48267

360049

10902

401568

68305

469874 104819

0.06

98923

26090

20038

717787

0.10

360049

105452

48267

200000

316937 94253 70602

0.06

246335

0.10

22963

4115

52570 47615

0.10

4984

4445

34217 32229

0.06

1988

1872

204700 185297

0.10

19403

13901

80374 72756

0.10

7618

6896

50582

50000

0.10

133808 26822

6339

285

10871 10902

NOTE 5 - OTHER CURRENT ASSETS As at May 31, 2026, other current assets consisted of $78,368 in prepaid expenses (May 31, 2025 - $3,400) and $29 in receivables associated with GST Cell MedX Canada paid on taxable supplies (May 31, 2025 - $3,241).

78368

3400

3241

NOTE 6 - SHARE CAPITAL Common stock issued during the year ended May 31, 2026 During the year ended May 31, 2026, the Company issued 750,000 shares valued at $250,000, under an agreement with an investor relations and public relations firm to provide services for an eight-month term, which commenced on March 18, 2025. The total fair value of these shares was measured based on the fair value of the shares issued in accordance with ASC 718 and recognized as part of corporate communications fees included in general and administrative expenses. On March 19, 2026, the Company issued 250,000 shares valued at $75,025 under an advisory services agreement with an investor relations firm for an initial twelve-month service period that commenced on March 12, 2026. The total fair value of these shares was measured in accordance with ASC 718, based on the fair value of the shares issued. The Company recognized $16,444 as corporate communications fees included in general and administrative expenses; the remaining $58,581 was recorded as prepaid expenses and will be allocated to corporate communications fees as services are provided during the remaining term of the agreement. Common stock issued during the year ended May 31, 2025 On March 24, 2025, the Company issued 75,000 shares of common stock in settlement of $15,000 owed to one of its vendors. At the time of the transaction, the fair value of the shares was $0.30; therefore, the Company recognized $7,500 loss on the settlement of debt. On March 18, 2025, the Company entered into an agreement with an investor relations and public relations firm to provide services for an eight-month term, commencing on the same date. Under the Agreement, the Company agreed to issue the consultant 125,000 shares in the Company’s common stock per month for services rendered at a deemed price of $0.20 per share over the eight-month service period for a total consideration of $200,000. As of May 31, 2025, the Company issued a total of 250,000 shares valued at $107,750, which was recognized as part of corporate communications fees included in general and administrative expenses. Options As at May 31, 2026 and 2025, the Company did not have any share purchase options issued and exercisable. Warrants The changes in the number of warrants outstanding during the years ended May 31, 2026 and 2025, are as follows: <table style="border-collapse:collapse;width:99%"><tr><td style="width:154.7pt;border-top:0.5pt solid #000000" valign="top"> </td><td colspan="3" style="width:146.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Year ended May 31, 2026 </td><td style="width:16.05pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td colspan="3" style="width:146.05pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Year ended May 31, 2025 </td></tr> <tr><td style="width:154.7pt;border-bottom:0.5pt solid #000000" valign="top"> </td><td style="width:67.2pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Number of warrants </td><td colspan="2" style="width:79.3pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Weighted average exercise price </td><td style="width:16.05pt" valign="bottom"> </td><td style="width:66.8pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Number of warrants </td><td colspan="2" style="width:79.25pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Weighted average exercise price </td></tr> <tr><td style="background-color:#DBE5F1;width:154.7pt;border-top:0.5pt solid #000000" valign="top">Warrants outstanding, beginning </td><td style="background-color:#DBE5F1;width:67.2pt;border-top:0.5pt solid #000000" valign="bottom">166,667 </td><td style="background-color:#DBE5F1;width:23.25pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.05pt;border-top:0.5pt solid #000000" valign="bottom">0.75 </td><td style="background-color:#DBE5F1;width:16.05pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:66.8pt;border-top:0.5pt solid #000000" valign="bottom">166,667 </td><td style="background-color:#DBE5F1;width:22.75pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.5pt;border-top:0.5pt solid #000000" valign="bottom">0.75 </td></tr> <tr><td style="width:154.7pt" valign="top">Warrants expired </td><td style="width:67.2pt" valign="bottom">(166,667) </td><td style="width:23.25pt" valign="bottom">$ </td><td style="width:56.05pt" valign="bottom">0.75 </td><td style="width:16.05pt" valign="bottom"> </td><td style="width:66.8pt" valign="bottom">- </td><td style="width:22.75pt" valign="bottom">$ </td><td style="width:56.5pt" valign="bottom">- </td></tr> <tr><td style="background-color:#DBE5F1;width:154.7pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top">Warrants outstanding, ending </td><td style="background-color:#DBE5F1;width:67.2pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#DBE5F1;width:23.25pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.05pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#DBE5F1;width:16.05pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:66.8pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">166,667 </td><td style="background-color:#DBE5F1;width:22.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.5pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">0.75 </td></tr> </table> All warrants expired unexercised on March 12, 2026.

750000

250000

75025

16444

58581

75000

15000

0.3

7500

the Company agreed to issue the consultant 125,000 shares in the Company’s common stock per month for services rendered at a deemed price of $0.20 per share over the eight-month service period for a total consideration of $200,000

250000

107750

<table style="border-collapse:collapse;width:99%"><tr><td style="width:154.7pt;border-top:0.5pt solid #000000" valign="top"> </td><td colspan="3" style="width:146.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Year ended May 31, 2026 </td><td style="width:16.05pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td colspan="3" style="width:146.05pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Year ended May 31, 2025 </td></tr> <tr><td style="width:154.7pt;border-bottom:0.5pt solid #000000" valign="top"> </td><td style="width:67.2pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Number of warrants </td><td colspan="2" style="width:79.3pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Weighted average exercise price </td><td style="width:16.05pt" valign="bottom"> </td><td style="width:66.8pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Number of warrants </td><td colspan="2" style="width:79.25pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000" valign="bottom">Weighted average exercise price </td></tr> <tr><td style="background-color:#DBE5F1;width:154.7pt;border-top:0.5pt solid #000000" valign="top">Warrants outstanding, beginning </td><td style="background-color:#DBE5F1;width:67.2pt;border-top:0.5pt solid #000000" valign="bottom">166,667 </td><td style="background-color:#DBE5F1;width:23.25pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.05pt;border-top:0.5pt solid #000000" valign="bottom">0.75 </td><td style="background-color:#DBE5F1;width:16.05pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:66.8pt;border-top:0.5pt solid #000000" valign="bottom">166,667 </td><td style="background-color:#DBE5F1;width:22.75pt;border-top:0.5pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.5pt;border-top:0.5pt solid #000000" valign="bottom">0.75 </td></tr> <tr><td style="width:154.7pt" valign="top">Warrants expired </td><td style="width:67.2pt" valign="bottom">(166,667) </td><td style="width:23.25pt" valign="bottom">$ </td><td style="width:56.05pt" valign="bottom">0.75 </td><td style="width:16.05pt" valign="bottom"> </td><td style="width:66.8pt" valign="bottom">- </td><td style="width:22.75pt" valign="bottom">$ </td><td style="width:56.5pt" valign="bottom">- </td></tr> <tr><td style="background-color:#DBE5F1;width:154.7pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="top">Warrants outstanding, ending </td><td style="background-color:#DBE5F1;width:67.2pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#DBE5F1;width:23.25pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.05pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#DBE5F1;width:16.05pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:66.8pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">166,667 </td><td style="background-color:#DBE5F1;width:22.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:56.5pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">0.75 </td></tr> </table>

166667

NOTE 7 - RESEARCH AND DEVELOPMENT In February 2025, the Company engaged ADM Tronics Unlimited, Inc (“ADM Tronics”) to redesigning its eBalance® microcurrent device. The Company expected the project to take approximately 22 to 34 weeks and to cost between $62,500 and $127,000. As of May 31, 2026, the Company and ADM Tronics continue working on the project at a regular hourly fee. During the year ended May 31, 2026, the Company incurred a total of $209,176 for this project, of which $203,534 was incurred under the agreement with ADM Tronics. As of May 31, 2026, the Company had spent a total of $258,597 with ADM Tronics since February 2025. On December 1, 2025, the Company entered into a service agreement to conduct a study examining the effects of the eBalance® microcurrent device. The study was expected to last three months and cost approximately $27,100. As of May 31, 2026, the Company made an initial payment of $13,546, which was recorded as a prepaid expense as the study was postponed until the new eBalance® microcurrent devices are ready for testing. The study began subsequent to May 31, 2026.

The Company expected the project to take approximately 22 to 34 weeks and to cost between $62,500 and $127,000

209176 203534 258597

13546

NOTE 8 - INCOME TAXES The reported income taxes differ from the amounts obtained by applying statutory rates to the loss before income taxes as follows: <table style="border-collapse:collapse;width:100%;border-bottom:3px double #000000"><tr><td style="width:264pt;border-top:0.25pt solid #000000;border-bottom:0.25pt solid #000000" valign="bottom"></td><td colspan="2" style="width:87.6pt;border-top:0.25pt solid #000000;border-bottom:0.25pt solid #000000" valign="bottom">May 31, 2026 </td><td style="width:20.25pt;border-top:0.25pt solid #000000;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:96.15pt;border-top:0.25pt solid #000000;border-bottom:0.25pt solid #000000" valign="bottom">May 31, 2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:264pt;border-top:0.25pt solid #000000" valign="bottom">Net loss </td><td style="background-color:#DBE5F1;width:24.25pt;border-top:0.25pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:63.35pt;border-top:0.25pt solid #000000" valign="bottom">(895,375) </td><td style="background-color:#DBE5F1;width:20.25pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:24.25pt;border-top:0.25pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:71.9pt;border-top:0.25pt solid #000000" valign="bottom">(566,293) </td></tr> <tr><td style="width:264pt;border-bottom:0.25pt solid #000000" valign="bottom">Statutory tax rate </td><td style="width:24.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="width:63.35pt;border-bottom:0.25pt solid #000000" valign="bottom">21% </td><td style="width:20.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="width:24.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="width:71.9pt;border-bottom:0.25pt solid #000000" valign="bottom">21% </td></tr> <tr><td style="background-color:#DBE5F1;width:264pt;border-top:0.25pt solid #000000" valign="bottom">Expected income tax recovery </td><td style="background-color:#DBE5F1;width:24.25pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:63.35pt;border-top:0.25pt solid #000000" valign="bottom">(188,000) </td><td style="background-color:#DBE5F1;width:20.25pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:24.25pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:71.9pt;border-top:0.25pt solid #000000" valign="bottom">(119,000) </td></tr> <tr><td style="width:264pt" valign="bottom">Effect of foreign exchange </td><td style="width:24.25pt" valign="bottom"> </td><td style="width:63.35pt" valign="bottom">4,000 </td><td style="width:20.25pt" valign="bottom"> </td><td style="width:24.25pt" valign="bottom"> </td><td style="width:71.9pt" valign="bottom">1,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:264pt" valign="bottom">Difference in statutory tax rate </td><td style="background-color:#DBE5F1;width:24.25pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:63.35pt" valign="bottom">(7,000) </td><td style="background-color:#DBE5F1;width:20.25pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:24.25pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:71.9pt" valign="bottom">(8,000) </td></tr> <tr><td style="width:264pt" valign="bottom">Permanent difference and other </td><td style="width:24.25pt" valign="bottom"> </td><td style="width:63.35pt" valign="bottom">14,000 </td><td style="width:20.25pt" valign="bottom"> </td><td style="width:24.25pt" valign="bottom"> </td><td style="width:71.9pt" valign="bottom">23,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:264pt;border-bottom:0.25pt solid #000000" valign="bottom">Change in unrecognized deductible temporary differences </td><td style="background-color:#DBE5F1;width:24.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:63.35pt;border-bottom:0.25pt solid #000000" valign="bottom">177,000 </td><td style="background-color:#DBE5F1;width:20.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:24.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:71.9pt;border-bottom:0.25pt solid #000000" valign="bottom">103,000 </td></tr> <tr><td style="width:264pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">Total income tax expense (recovery) </td><td style="width:24.25pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:63.35pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td><td style="width:20.25pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom"> </td><td style="width:24.25pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:71.9pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td></tr> </table> The Company’s tax-effected future income tax assets and liabilities are estimated as follows: <table style="border-collapse:collapse;width:80%"><tr><td style="width:185.4pt;border-top:0.25pt solid #000000" valign="bottom"></td><td colspan="2" style="width:91.15pt;border-top:0.25pt solid #000000" valign="bottom">May 31, 2026 </td><td style="width:15pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:82.85pt;border-top:0.25pt solid #000000" valign="bottom">May 31, 2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:185.4pt;border-top:0.25pt solid #000000" valign="top">Deferred income tax assets (liabilities) </td><td style="background-color:#DBE5F1;width:22.8pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:68.35pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:15pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:22.8pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:60.05pt;border-top:0.5pt solid #000000" valign="bottom"> </td></tr> <tr><td style="width:185.4pt" valign="top">Net operating losses - US </td><td style="width:22.8pt" valign="bottom">$ </td><td style="width:68.35pt" valign="bottom">1,638,000 </td><td style="width:15pt" valign="bottom"> </td><td style="width:22.8pt" valign="bottom">$ </td><td style="width:60.05pt" valign="bottom">1,487,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:185.4pt" valign="top">Net-capital losses - Canada </td><td style="background-color:#DBE5F1;width:22.8pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:68.35pt" valign="bottom">518,000 </td><td style="background-color:#DBE5F1;width:15pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:22.8pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:60.05pt" valign="bottom">492,000 </td></tr> <tr><td style="width:185.4pt" valign="top">Equipment </td><td style="width:22.8pt" valign="bottom"> </td><td style="width:68.35pt" valign="bottom">1,000 </td><td style="width:15pt" valign="bottom"> </td><td style="width:22.8pt" valign="bottom"> </td><td style="width:60.05pt" valign="bottom">1,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:185.4pt;border-bottom:0.25pt solid #000000" valign="top">Less: Unrecognized deferred tax assets </td><td style="background-color:#DBE5F1;width:22.8pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:68.35pt;border-bottom:0.5pt solid #000000" valign="bottom">(2,157,000) </td><td style="background-color:#DBE5F1;width:15pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:22.8pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:60.05pt;border-bottom:0.5pt solid #000000" valign="bottom">(1,980,000) </td></tr> <tr><td style="width:185.4pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="top">Net deferred income tax assets </td><td style="width:22.8pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:68.35pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td><td style="width:15pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"> </td><td style="width:22.8pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:60.05pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td></tr> </table> At May 31, 2026 and 2025, the Company has recorded a valuation allowance for the aggregate of its tax assets as management believes it is more likely than not that the deferred tax asset will not be realized. At May 31, 2026, the Company had federal and state net operating loss carry forwards of approximately $7,801,000, $2,054,000 of which expire by 2037. The remaining balance of $5,747,000 will never expire but its utilization is limited to 80% of taxable income in any future year. As at May 31, 2026, the Company also had non-capital loss carry forwards of approximately $2,000,000 (2025 - $1,886,000) to reduce future Canadian taxable income. These losses expire in 2038 to 2046. The Company has evaluated all tax positions for open years and has concluded that they have no material unrecognized tax benefits or penalties. It is not anticipated that unrecognized tax benefits would significantly increase or decrease within 12 months of the reporting date. The Company recognizes interest and penalties related to unrecognized tax benefits in interest expense and penalties within operating expenses. The Company’s federal income tax returns for fiscal years 2023 through 2026 remain open and subject to examination. Tax attributes from prior years can be adjusted during an IRS audit.

<table style="border-collapse:collapse;width:100%;border-bottom:3px double #000000"><tr><td style="width:264pt;border-top:0.25pt solid #000000;border-bottom:0.25pt solid #000000" valign="bottom"></td><td colspan="2" style="width:87.6pt;border-top:0.25pt solid #000000;border-bottom:0.25pt solid #000000" valign="bottom">May 31, 2026 </td><td style="width:20.25pt;border-top:0.25pt solid #000000;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:96.15pt;border-top:0.25pt solid #000000;border-bottom:0.25pt solid #000000" valign="bottom">May 31, 2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:264pt;border-top:0.25pt solid #000000" valign="bottom">Net loss </td><td style="background-color:#DBE5F1;width:24.25pt;border-top:0.25pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:63.35pt;border-top:0.25pt solid #000000" valign="bottom">(895,375) </td><td style="background-color:#DBE5F1;width:20.25pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:24.25pt;border-top:0.25pt solid #000000" valign="bottom">$ </td><td style="background-color:#DBE5F1;width:71.9pt;border-top:0.25pt solid #000000" valign="bottom">(566,293) </td></tr> <tr><td style="width:264pt;border-bottom:0.25pt solid #000000" valign="bottom">Statutory tax rate </td><td style="width:24.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="width:63.35pt;border-bottom:0.25pt solid #000000" valign="bottom">21% </td><td style="width:20.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="width:24.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="width:71.9pt;border-bottom:0.25pt solid #000000" valign="bottom">21% </td></tr> <tr><td style="background-color:#DBE5F1;width:264pt;border-top:0.25pt solid #000000" valign="bottom">Expected income tax recovery </td><td style="background-color:#DBE5F1;width:24.25pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:63.35pt;border-top:0.25pt solid #000000" valign="bottom">(188,000) </td><td style="background-color:#DBE5F1;width:20.25pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:24.25pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:71.9pt;border-top:0.25pt solid #000000" valign="bottom">(119,000) </td></tr> <tr><td style="width:264pt" valign="bottom">Effect of foreign exchange </td><td style="width:24.25pt" valign="bottom"> </td><td style="width:63.35pt" valign="bottom">4,000 </td><td style="width:20.25pt" valign="bottom"> </td><td style="width:24.25pt" valign="bottom"> </td><td style="width:71.9pt" valign="bottom">1,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:264pt" valign="bottom">Difference in statutory tax rate </td><td style="background-color:#DBE5F1;width:24.25pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:63.35pt" valign="bottom">(7,000) </td><td style="background-color:#DBE5F1;width:20.25pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:24.25pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:71.9pt" valign="bottom">(8,000) </td></tr> <tr><td style="width:264pt" valign="bottom">Permanent difference and other </td><td style="width:24.25pt" valign="bottom"> </td><td style="width:63.35pt" valign="bottom">14,000 </td><td style="width:20.25pt" valign="bottom"> </td><td style="width:24.25pt" valign="bottom"> </td><td style="width:71.9pt" valign="bottom">23,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:264pt;border-bottom:0.25pt solid #000000" valign="bottom">Change in unrecognized deductible temporary differences </td><td style="background-color:#DBE5F1;width:24.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:63.35pt;border-bottom:0.25pt solid #000000" valign="bottom">177,000 </td><td style="background-color:#DBE5F1;width:20.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:24.25pt;border-bottom:0.25pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:71.9pt;border-bottom:0.25pt solid #000000" valign="bottom">103,000 </td></tr> <tr><td style="width:264pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">Total income tax expense (recovery) </td><td style="width:24.25pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:63.35pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td><td style="width:20.25pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom"> </td><td style="width:24.25pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:71.9pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td></tr> </table>

-895375

-566293

0.21

-188000

-119000

4000

1000

-7000

-8000

14000

23000

177000

103000

<table style="border-collapse:collapse;width:80%"><tr><td style="width:185.4pt;border-top:0.25pt solid #000000" valign="bottom"></td><td colspan="2" style="width:91.15pt;border-top:0.25pt solid #000000" valign="bottom">May 31, 2026 </td><td style="width:15pt;border-top:0.25pt solid #000000" valign="bottom"> </td><td colspan="2" style="width:82.85pt;border-top:0.25pt solid #000000" valign="bottom">May 31, 2025 </td></tr> <tr><td style="background-color:#DBE5F1;width:185.4pt;border-top:0.25pt solid #000000" valign="top">Deferred income tax assets (liabilities) </td><td style="background-color:#DBE5F1;width:22.8pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:68.35pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:15pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:22.8pt;border-top:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:60.05pt;border-top:0.5pt solid #000000" valign="bottom"> </td></tr> <tr><td style="width:185.4pt" valign="top">Net operating losses - US </td><td style="width:22.8pt" valign="bottom">$ </td><td style="width:68.35pt" valign="bottom">1,638,000 </td><td style="width:15pt" valign="bottom"> </td><td style="width:22.8pt" valign="bottom">$ </td><td style="width:60.05pt" valign="bottom">1,487,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:185.4pt" valign="top">Net-capital losses - Canada </td><td style="background-color:#DBE5F1;width:22.8pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:68.35pt" valign="bottom">518,000 </td><td style="background-color:#DBE5F1;width:15pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:22.8pt" valign="bottom"> </td><td style="background-color:#DBE5F1;width:60.05pt" valign="bottom">492,000 </td></tr> <tr><td style="width:185.4pt" valign="top">Equipment </td><td style="width:22.8pt" valign="bottom"> </td><td style="width:68.35pt" valign="bottom">1,000 </td><td style="width:15pt" valign="bottom"> </td><td style="width:22.8pt" valign="bottom"> </td><td style="width:60.05pt" valign="bottom">1,000 </td></tr> <tr><td style="background-color:#DBE5F1;width:185.4pt;border-bottom:0.25pt solid #000000" valign="top">Less: Unrecognized deferred tax assets </td><td style="background-color:#DBE5F1;width:22.8pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:68.35pt;border-bottom:0.5pt solid #000000" valign="bottom">(2,157,000) </td><td style="background-color:#DBE5F1;width:15pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:22.8pt;border-bottom:0.5pt solid #000000" valign="bottom"> </td><td style="background-color:#DBE5F1;width:60.05pt;border-bottom:0.5pt solid #000000" valign="bottom">(1,980,000) </td></tr> <tr><td style="width:185.4pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000" valign="top">Net deferred income tax assets </td><td style="width:22.8pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:68.35pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td><td style="width:15pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"> </td><td style="width:22.8pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:60.05pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">- </td></tr> </table>

1638000

1487000

518000

492000

1000

2157000

1980000

7801000

2054000

2000000 1886000

NOTE 9 - SUBSEQUENT EVENT On July 16, 2026, the Company amended the terms of its unsecured line of credit agreement with Mr. Richard Jeffs, increasing the borrowing limit from $200,000 to $350,000. All other terms of the agreement remained unchanged. Subsequent to May 31, 2026, the Company borrowed an additional $50,000 under this line of credit. In addition, Mr. Jeffs advanced CAD$85,000 to the Company under the existing CAD$100,000 line of credit.

50000